Samsung BioLogics
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
July 23, 2026CDMO, PolyPeptide, Samsung BioLogics, acquisition
Samsung Biologics has launched an all-cash public tender offer to acquire PolyPeptide Group in a deal valued at approximately CHF1.46bn, …
Samsung Biologics and Kurma Partners announce collaboration for development and manufacturing of biologics
October 24, 2023Business Services Kurma Partners, Pharmacy, Samsung BioLogics
Samsung Biologics and Kurma Partners have announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ …
Samsung Biologics names John Rim as CEO and President
December 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics
Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …
AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal
September 22, 2020Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma
AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …
Samsung BioLogics delisted over accounting violations
November 14, 2018Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea
South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …
Samsung BioLogics’ shares down $6bn after accounting furore
May 2, 2018Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD
October 30, 2017Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma
Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …
Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug
July 4, 2017Manufacturing and Production Samsung BioLogics, Sun Pharma
India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …
Latest content
FibroFind appoints Lee Borthwick as CEO
